[Pharm-policy] Bob Huff on Griffin Securities report on HIV/AIDS drug market]

[James Love]

-------- Original Message --------
Subject: RE: FW: [Pharm-policy] Griffin Securities report on HIV/AIDS
drug market
Date: Tue, 24 Jul 2001 08:38:09 -0400
From: "Bob Huff" <bobine@earthlink.net>
To: "James Love" <love@cptech.org>

Bob Huff wrote:

This report actually seems to be touting an OTC stock, Aethlon Medical,
which is developing an extracorporeal blood purifier to remove HIV by
dialysis. They are out of money and may be trying to push out some new
stock. The report itself is not bad (there are a few factual errors),
but it's more
than a tad odd for Aethlon to appear so prominently. Aethlon has paid a
company (US Stockreports) to send out authoritative-sounding press
releases. They may have sponsored this report also.

It doesn't makes sense medically... extracorporeal blood cleaning was
looked at in the eighties, but nothing became of it. Removing the excess
virus from the blood wouldn't do anything about the virus in tissues
where all the infection is happening. A look at their SEC filings shows:
The inventor is 76 years old and has retired. They have 3 paid employees
- none an MD. Their patents are about to expire.
They're incorporated in the state of Nevada (not that there's anything
wrong with that...) Mostly, they seem to be seriously broke.